4-bromo-a-23187 has been researched along with caffeine in 3 studies
| Studies (4-bromo-a-23187) | Trials (4-bromo-a-23187) | Recent Studies (post-2010) (4-bromo-a-23187) | Studies (caffeine) | Trials (caffeine) | Recent Studies (post-2010) (caffeine) |
|---|---|---|---|---|---|
| 63 | 0 | 5 | 25,501 | 2,393 | 6,825 |
| Protein | Taxonomy | 4-bromo-a-23187 (IC50) | caffeine (IC50) |
|---|---|---|---|
| Acetylcholinesterase | Homo sapiens (human) | 7.25 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gylfe, E; Hellman, B; Tengholm, A | 1 |
| Ali, Z; Kargacin, GJ; Kargacin, ME; Pollock, NS; Ward, CA | 1 |
| Atwood, HL; Deitcher, DL; Gu, T; Hewes, RS; Klose, MK; Levitan, ES; Shakiryanova, D; Zhou, Y | 1 |
3 other study(ies) available for 4-bromo-a-23187 and caffeine
| Article | Year |
|---|---|
Mobilization of Ca2+ stores in individual pancreatic beta-cells permeabilized or not with digitonin or alpha-toxin.
Topics: Adenosine Diphosphate Ribose; Adenosine Triphosphate; Animals; Bacterial Toxins; Caffeine; Calcimycin; Calcium; Calcium-Transporting ATPases; Cell Compartmentation; Cell Membrane Permeability; Cyclic ADP-Ribose; Cytoplasm; Digitonin; Enzyme Inhibitors; Hemolysin Proteins; Inositol 1,4,5-Trisphosphate; Ionophores; Islets of Langerhans; Mice; Mice, Obese; NADP; Organelles; Ryanodine; Ryanodine Receptor Calcium Release Channel; Thapsigargin | 2000 |
Tamoxifen inhibits Ca2+ uptake by the cardiac sarcoplasmic reticulum.
Topics: Animals; Caffeine; Calcimycin; Calcium; Calcium Channels; Calcium-Transporting ATPases; Estrogen Antagonists; Ionophores; Male; Myocardium; Potassium Channels; Rats; Rats, Sprague-Dawley; Sarcoplasmic Reticulum; Tamoxifen; Thapsigargin | 2000 |
Presynaptic ryanodine receptor-activated calmodulin kinase II increases vesicle mobility and potentiates neuropeptide release.
Topics: Animals; Animals, Genetically Modified; Caffeine; Calcimycin; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Drosophila; Drosophila Proteins; Drug Interactions; Electric Stimulation; Enzyme Inhibitors; Green Fluorescent Proteins; Hot Temperature; Larva; Mutation; Neuromuscular Junction; Neuropeptides; Phosphodiesterase Inhibitors; Presynaptic Terminals; Ryanodine; Ryanodine Receptor Calcium Release Channel; Synaptic Vesicles | 2007 |